Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes

Panlilio, 1992, Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975–1991, Infect Control Hosp Epidemiol, 13, 582, 10.2307/30148460

Sunada, 2003, Report of questionnaire survey for methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae between 1998 and 2000 in the Kinki district, Kansenshogaku Zasshi, 77, 331, 10.11150/kansenshogakuzasshi1970.77.331

Noguchi, 2006, Antimicrobial agent of susceptibilities and antiseptic resistance gene distribution among methicillin-resistant Staphylococcus aureus isolates from patients with impetigo and staphylococcal scalded skin syndrome, J Clin Microbiol, 44, 2119, 10.1128/JCM.02690-05

Sader, 2006, Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002–2004), Clin Microbiol Infect, 12, 844, 10.1111/j.1469-0691.2006.01550.x

Jones, 2004, Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American surveillance study (2000–2002), Ann Clin Microbiol Antimicrob, 3, 1, 10.1186/1476-0711-3-1

Hiramatsu, 1997, Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility, J Antimicrob Chemother, 40, 135, 10.1093/jac/40.1.135

Fridkin, 2003, Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997–2001, Clin Infect Dis, 36, 429, 10.1086/346207

2002, Public Health Dispatch: vancomycin-resistant Staphylococcus aureus – Pennsylvania, 2002, Morb Mortal Wkly Rep, 51, 902

2002, Staphylococcus aureus resistant to vancomycin – United States, 2002, Morb Mortal Wkly Rep, 51, 565

2004, Vancomycin-resistant Staphylococcus aureus – New York, 2004, Morb Mortal Wkly Rep, 53, 322

Kim, 2004, In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey, Antimicrob Agents Chemother, 48, 1124, 10.1128/AAC.48.4.1124-1127.2004

Ida, 2001, Identification of AMEs by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan, J Clin Microbiol, 39, 3115, 10.1128/JCM.39.9.3115-3121.2001

Llano-Sotelo, 2002, Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site, Chem Biol, 9, 455, 10.1016/S1074-5521(02)00125-4

Kotra, 2000, Aminoglycosides: perspec-tives on mechanisms of action and resistance and strategies to counter resistance, Antimicrob Agents Chemother, 44, 3249, 10.1128/AAC.44.12.3249-3256.2000

Tanaka, 1983, Mechanism of action of habekacin, a novel amino acid-containing aminoglycoside antibiotic, Antimicrob Agents Chemother, 24, 797, 10.1128/AAC.24.5.797

Ubukata, 1984, Purification and characterization of AMEs from Staphylococcus aureus and Staphylococcus epidermidis, Antimicrob Agents Chemother, 25, 754, 10.1128/AAC.25.6.754

Tabata, 2003, Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA), Jpn J Antibiot, 56, 36

Ishino, 2004, Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance, J Antibiot, 57, 679, 10.7164/antibiotics.57.679

2005

Saito, 1995, Clinical breakpoints for antimicrobial agents in pulmonary infections and sepsis: Report of The Committee for Japanese Standards for Antimicrobial Susceptibility Testing for Bacteria, J Infect Chemother, 1, 83, 10.1007/BF02347736

Tsuchizaki, 2000, Colony PCR for rapid detection of antibiotic resistance genes in MRSA and enterococci, Jpn J Antibiot, 53, 422

Hotta, 1999, Necessity and usefulness of detection by PCR of mecA and aac(6′)/aph(2″) genes for identification of arbekacin-resistant MRSA, Jpn J Antibiot, 52, 525

Vanhoof, 1994, Detection by polymerase chain reaction of genes encoding AMEs in methicillin-resistant Staphylococcus aureus isolates of epidemic phage types, J Med Microbiol, 41, 282, 10.1099/00222615-41-4-282

Tsuchizaki, 2006, Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000), J Antibiot, 59, 229, 10.1038/ja.2006.32

Kondo, 1999, Semisynthetic aminoglycoside antibiotics: development and enzymatic modifications, J Infect Chemother, 5, 1, 10.1007/s101560050001

Ardic, 2006, Investigation of aminoglycoside modifying enzyme genes in methicillin-resistant staphylococci, Microbiol Res, 161, 49, 10.1016/j.micres.2005.05.002

Schmitz, 1999, The prevalence of aminoglycoside resistance and corresponding genes in clinical isolates of staphylococci from 19 European hospitals, J Antimicrob Chemother, 43, 253, 10.1093/jac/43.2.253

Choi, 2003, Multiplex PCR for the detection of genes encoding aminoglycoside modifying enzymes and methicillin resistance among Staphylococcus species, J Korean Med Sci, 18, 631, 10.3346/jkms.2003.18.5.631

Matsuo, 2003, Molecular mechanism for the enhancement of arbekacin resistance in a methicillin-resistant Staphylococcus aureus, FEBS Lett, 546, 401, 10.1016/S0014-5793(03)00644-6